COMPARATIVE STUDY OF PREVALENCE OF POLYCYSTIC OVARIAN SYNDROME IN RURAL AND URBAN POPULATION

Similar documents
A study of clinical manifestations of PCOS among obese and non- obese rural women

Awareness of PCOS (polycystic ovarian syndrome) in adolescent and young girls

SCREENING OF POLYCYSTIC OVARIAN SYNDROME AMONG ADOLESCENT GIRLS AT CAIRO UNIVERSITY

Prevalence of Polycystic Ovarian Syndrome among urban adolescent girls and young women in Mumbai

Study of clinical presentation in cases of Polycystic Ovarian Syndrome in rural population

12/13/2017. Important references for PCOS. Polycystic Ovarian Syndrome (PCOS) for the Family Physician. 35 year old obese woman

Dr Stella Milsom. Endocrinologist Fertility Associates Auckland. 12:30-12:40 When Puberty is PCO

INSULIN RESISTANCE, POLYCYSTIC OVARIAN SYNDROME An Overview

Polycystic Ovary Syndrome HEATHER BURKS, MD OU PHYSICIANS REPRODUCTIVE MEDICINE SEPTEMBER 21, 2018

International Journal of Current Medical And Applied Sciences.vol.1. Issue: 1, 2013, PP 11-15

Comparative study of metabolic profile of women presenting with polycystic ovary syndrome in relation to body mass index

Prevalence and symptomatology of polycystic ovarian syndrome in Indian women: is there a rising incidence?

Polycystic Ovary Syndrome

Prevalence of polycystic ovarian syndrome in the Buraimi region of Oman

Hyperandrogenism. Dr Jack Biko. MB. BCh (Wits), MMED O & G (Pret), FCOG (SA), Dip Advanced Endoscopic Surgery(Kiel, Germany)

Pregnancy outcome in women with polycystic ovary syndrome

Determining the insulin resistance rate in Polycystic Ovary Syndrome patients (PCOs)

Polycystic Ovary Syndrome (PCOS):

ROLE OF HORMONAL ASSAY IN DIAGNOSING PCOD DR GAANA SREENIVAS (JSS,MYSURU)

Overview of Reproductive Endocrinology

Polycystic Ovary Syndrome

PCOS Awareness Symposium Atlanta September 24 th, Preventing Diabetes & Cardiovascular Disease in PCOS

12/27/2013. Kristen Cain, MD FACOG Reproductive Medicine Institute Sanford Health, Fargo ND

From the editors desk

Polycystic Ovarian Syndrome (PCOS) LOGO

Epidemiological correlates among women with Polycystic ovary syndrome in South India

Pattern of dermatologic manifestations in polycystic ovarian disease cases from a tertiary care hospital

THYROID PROFILE IN POLYCYSTIC OVARIAN SYNDROME Sudhanshu Sekhara Nanda 1, Subhalaxmi Dash 2, Ashok Behera 3, Bharati Mishra 4

X/06/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 91(1):2 6 Copyright 2006 by The Endocrine Society doi: /jc.

Case Questions. Polycystic Ovarian Syndrome: Treatment Goals and Options. Differential Diagnosis of Hyperandrogenic Anovulation

PCOS and Obesity DUB is better treated by OCPs

Cam type Femoroacetabular Impingement associated with Marker for Hyperandrogenism in Women

Metabolic syndrome in females with polycystic ovary syndrome and International Diabetes Federation criteria

A STUDY OF CLINICAL PARAMETERS IN THE DIAGNOSIS OF POLYCYSTIC OVARIAN SYNDROME Soumya Ranjan Panda 1, K. Durgavati 2, Santhosh Kumar Sahu 3

3. Metformin therapy for PCOS

The Impact of Insulin Resistance on Long-Term Health in PCOS

Title of Guideline (must include the word Guideline (not protocol, policy, procedure etc)

What every dermatologist should know about Polycystic Ovary Syndrome (PCOS)

Case. 24 year old female presented to your office complaining of excess hair growth on her face and abdomen. Questions?

New PCOS guidelines: What s relevant to general practice

UNDERSTANDING PCOS AND ITS DIAGNOSIS

JMSCR Vol 05 Issue 05 Page May 2017

JMSCR Vol 05 Issue 04 Page April 2017

Clinical Profile Polycystic Ovarian Syndrome Cases

PCOS IN ADOLESCENTS: EARLY DETECTION AND INTERVENTION

WHY NEW DIAGNOSTIC CRITERIA FOR DIFFERENT PCOS PHENOTYPES ARE URGENTLY NEEDED

Manipal & Apollo Spectra Hospital. Special Interest:Laparoscopy & Bariatric Surgery

16 YEAR-OLD OBESE FEMALE WITH OLIGOMENORRHEA

Metformin and Pioglitazone in Polycystic Ovarian Syndrome: A Comparative Study

Can Sex hormone Binding Globulin Considered as a Predictor of Response to Pharmacological Treatment in Women with Polycystic Ovary Syndrome?

Nitasha Garg 1 Harkiran Kaur Khaira. About the Author

Risk of Developing Polycystic Ovarian Syndrome- Adolescent Girls

Polycystic Ovary Syndrome

Polycystic Ovarian Syndrome: Diagnosis, Preconceptional Management and Health Risks

On Diseases Of Menstruation And Ovarian READ ONLINE

ASSOCIATION OF INSULIN RESISTANCE AND SERUM 25 OH VITAMIN-D IN INDIAN WOMEN WITH POLYCYSTIC OVARY SYNDROME

What is PCOS? PCOS THE CONQUER PCOS E-BOOK. You'll be amazed when you read this...

POLYCYSTIC OVARIAN SYNDROME Laura Tatpati, MD Reproductive Endocrinology and Infertility. Based on: ACOG No. 108 Oct 2009; reaffirmed 2015

International Journal of Health Sciences and Research ISSN:

Prevalence of Anovulation in Subfertile Women in Kerbala 2012, A descriptive Cross-Sectional Study

Polycystic Ovary Syndrome

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

Polycystic ovary syndrome

Polycystic ovary syndrome (PCOS)

Polycystic Ovarian Syndrome: Diagnosis, Preconceptional Management and Health Risks. Kate D. Schoyer, M.D. May 6, 2016

International Academy of Engineering and Medical Research, 2018 Volume-3, Issue-1 Published Online January 2018 in IAEMR (

Estimation of serum 25 hydroxy vitamin D level and its correlation with metabolic and endocrine dysregulation in women with PCOS

CORRELATION OF OBESITY, INSULIN RESISTANCE AND LIPID PROFILE IN WOMEN WITH PCOS IN KIMS HOSPITAL BANGALORE Shashikala H. Gowda 1, Mansi Dhingra 2

CREATING A PCOS TREATMENT PLAN. Ricardo Azziz, M.D., M.P.H., M.B.A. Georgia Regents University

Polycystic Ovary Syndrome (PCOS)

The prevalence of polycystic ovary syndrome in Iranian women based on different diagnostic criteria

METABOLIC RISK MARKERS IN WOMEN WITH POLYCYSTIC OVARIAN MORPHOLOGY

REI CASE(S) Laura L. Tatpati, MD Division of REI, Dept of OB/GYN KUSM - W

Research Article. Ramanand SJ 1, Raparti GT 2 *, Halasawadekar NR 1, Ramanand JB 3, Kumbhar AV 1, Shah RD 1

UPDATE: Women s Health Issues

INFERTILITY CAUSES. Basic evaluation of the female

Clinical Guideline ADRENARCHE MANAGEMENT OF CHILDREN PRESENTING WITH SIGNS OF EARLY ONSET PUBIC HAIR/BODY ODOUR/ACNE

Structured teaching programme on knowledge about polycystic ovarian syndrome among adolescent girls

Amenorrhoea: polycystic ovary syndrome

Awareness of Polycystic Ovarian Disease among Females of Age Group Years

Metfornim and Pioglitazone in polycystic ovarian syndrome: A comparative study

PCOS. Reproductive Gynaecology and Infertility. Dr.Renda Bouzayen MD.FRCSC GREI,OBGYN Dalhousie University

Female Reproductive Endocrinology

ASSOCIATION OF ANXIETY DISORDER IN WOMEN WITH POLYCYSTIC OVARIAN SYNDROME Sumbul Sohail 1, Rubina Salahuddin 1, Shabnum Nadeem 1

Antithyroid Peroxidase Antibodies in Women with Polycystic Ovary Syndrome

Prevalence of Polycystic Ovarian Syndrome among Female Students: A Cross-Sectional Study

Polycystic Ovarian Syndrome. Heidi Hallonquist, MD Concord Hospital Concord Obstetrics and Gynecology


POLYCYSTıC OVARY SYNDROME (PCOS) New Perspectives. Michel Abou Abdallah, MD. Reproductive Endocrinology

Polycystic Ovary Syndrome: Cardiovascular Disease risk

Risk Factors Contributing to Hirsutism

13 th Annual Women s Health Day PCOS. Saturday 02/09/2017 Dr Mathias Epee-Bekima O&G Consultant KEMH

What is polycystic ovary syndrome? What are polycystic ovaries? What are the symptoms of PCOS?

POLYCYSTIC OVARY SYNDROME INA S. IRABON,MD, FPOGS,FPSRM,FPSGE OBSTETRICS AND GYNECOLOGY REPRODUCTIVE ENDOCRINOLOGY AND INFERTILITY

Correlation of prolactin and thyroid disorders in infertile women

Information for you. What is polycystic ovary syndrome? Polycystic ovary syndrome: what it means for your long-term health

POLYCYSTIC OVARIAN SYNDROME WHERE WE ARE AT IN 2018

The Relation between Diverse Phenotypes of PCOS with Clinical Manifestations, Anthropometric Indices and Metabolic Characteristics

Reproductive Health in Non Alcoolic Fatty Liver Disease (NAFLD)

Polycystic Ovary Disease: A Common Endocrine Disorder in Women

Transcription:

ORIGINAL ARTICLE COMPARATIVE STUDY OF PREVALENCE OF POLYCYSTIC OVARIAN SYNDROME IN RURAL AND URBAN POPULATION Penagaluru Radha 1, Rama Sarala Devi 2, Jalagam Madhavi 3 1,2 Associate Professor, 3 Post graduate, Department of Gynaecology and Obstetrics, Kakatiya Medical College, Warangal, Telangana. ABSTRACT: Introduction: The occurrence of polycystic ovarian syndrome has been associated with an increased risk for Type 2 diabetes, gestational diabetes, hypertension, and gynaecological cancers. Aim : The present study hypothesize that the burden of PCOS will be considerably lower among rural Indian adolescents compared to their urban counterparts. Materials and methods: This study includes 100 cases, 50 from urban and 50 from rural for a period of 2 yrs in reproductive age group who had attended the outpatient with the clinical symptoms of Oligomennorhea /amenorrhea, clinical signs of hyperandrogenism, hirsutism and acne and at least one ovary with 12 or more 2-9mm follicles and/or increased volume. Results: Most of the urban participants are from Nuclear Family structure when compared to rural. (88% vs 64%). The proportion of individuals with oligomenorrhoea were higher among urban participants compared to rural counterparts. Participants had higher proportion of individuals with recent weight gain in comparison with rural participants. The proportion of participants from urban areas are more obese than their rural counterparts. The urban participants had a higher frequency of excess androgen activity which was evidenced by Hirsutism. Involvement in vigorous work activity was significantly higher among rural. There was no statistically significant difference for serum testosterone level of the rural and urban participants. The proportion of participants diagnosed with polycystic ovarian syndrome serum Insulin levels in rural verses urban (40% verses 44%). The proportion of participants diagnosed with polycystic ovarian syndrome having polycystic ovaries on ultrasonography finding in rural and urban (74% Vs 76%). Conclusion: The reported younger onset of this syndrome and the prevalence of associated risk factors such as glucose intolerance in the Indian population signified a need for intensified efforts in early detection. Key words: Oligomennorhea, Hirsutism, Glucose intolerance. Corresponding author: Dr. Penagaluru Radha, H.no: Flat no -502, Uppula apartments, Beside MGM Hospital, Warangal, Telangana. This article may be cited as: Radha P, Devi RS, Madhavi J. Comparative study of prevalence of polycystic ovarian syndrome in rural and urban population. J Adv Med Dent Scie Res 2016;4(2):90-95. I NTRODUCTION Polycystic ovarian syndrome (PCOS) has been defined by the National Institute of Health and Rotterdam criteria as a hormonal disorder characterized by the presence of at least one polycystic ovary (presence of multiple cysts) accompanied by ovulatory dysfunction and excessive secretion of androgens. 1 The occurrence of polycystic ovarian syndrome has been associated with an increased risk for Type 2 diabetes, gestational diabetes, hypertension, and gynaecological cancers. 1,2 Studies have reported 10 times greater risk of developing Type 2 diabetes in women affected by PCOS of polycystic ovarian syndrome ranges from 2.2 to 26%. 3 The rates of polycystic ovarian syndrome have been reportedly high among Indian women compared to their Caucasian counterparts, with an estimated prevalence of 9.13% in Indian adolescents. 3, 4 Clinical presentations of polycystic ovarian syndrome include abnormal facial and skin hair growth (hirsutism), acne, and irregular or absence of menstrual periods. 5 However acne is most common during adolescent phase of life and there is limited literature on adolescent androgenic alopecia 6. Differential diagnosis of PCOS includes congenital adrenal hyperplasia (late onset), Cushing syndrome, hyperprolactinemia, 901

hypothyroidism, and ovarian and adrenal androgen secreting tumours 6. Different categories in the clinical presentations of PCOS have been distinguished according to the Rotterdam criteria 5. They include (I) Classic PCOS characterized by the presence or absence of ovarian cysts with excessive androgen secretion and irregular menstrual periods, (ii) Ovulatory PCOS characterized by the presence of increased androgen secretion and multiple cysts and (iii) Non-androgenic PCOS associated with irregular menstruation and multiple cysts. 5 The determinants of polycystic ovarian syndrome have been linked to both hereditary and environmental factors. 1 The attributed hereditary factors include early age of sexual maturation, premature foetal development, and family history of PCOS among first-degree relatives. 1,7 Studies have reported an earlier age at diagnosis of PCOS (9 12 years) among adolescent females with earlier maturation of sexual characteristics compared to their later counterparts (13 18 years). 7 This has been attributed to an increased androgen secretion associated with early onset of puberty. 1 It has been reported that premature fetal development leads to an earlier and more rapid onset of puberty with an increased risk of developing PCOS. Clinical manifestations of associated symptoms such as hyper-insulinemia have also been observed in offspring of PCOS affected women long before the onset of puberty affirming the role of family history. 8 The associated environmental factors reported include physical inactivity, obesity, and its associated insulin resistance. Insulin resistance which is of high prevalence in the Indian population 5 has been consistently reported as a strong determining factor for the occurrence of PCOS in Indian adults and adolescents. 1 While several studies have reported an association between excessive androgen secretion and the occurrence of insulin resistance in affected women, temporality has not been established. 1 There are marked variations in the prevalence of insulin resistance across different geographical regions of India and among urban and rural settings. 9 A higher prevalence of insulin resistance has been observed in urban Indian populations compared to their rural counterparts. 9 This is suggestive that a marked difference could exist in the prevalence of PCOS among different settings. Since the clinical manifestations of PCOS have been consistently observed in early adolescence, the increased risk of developing Type 2 diabetes and its associated comorbidities during later years can be controlled by identifying high risk populations and implementing preventive measures. However, the nature of the environmental and lifestyle determinants of PCOS including physical activity and obesity is suggestive of the fact that variations could exist in the prevalence of PCOS in urban and rural settings due to dissimilar dietary practices and the level of physical activity. Such results could foster the implementation of lifestyle preventive measures for PCOS and its associated co morbidities in different settings at an earlier stage. Although studies have reported the prevalence of PCOS in Indian adolescents, no studies have examined the differences in prevalence rates in urban and rural settings. The present studies hypothesize that the burden of PCOS will be considerably lower among rural Indian adolescents compared to their urban counterparts. MATERIALS AND METHODS It is a Prospective study was done in the department of Obstetrics and Gynaecology of Government Maternity Hospital, Hanamkonda from November 2013 to November 2015. The study was conducted after taking approval of ethical committee. This study includes 100 cases of which 50 from urban and 50 rural of reproductive age group who had attended outpatient department of obstetrics and gynaecology. Inclusion Criteria: Oligomennorhea (intermenstrual interval>35 days with less than 8 menstrual bleedings in the past year) or amenorrhea (absent menstrual bleeding or no menstrual bleeding in the past 90 days). Clinical signs of hyperandrogenism, hirsutism and acne. Polycystic ovarian morphology at least one ovary with 12 or size of more than 2-9 mm follicles and/or increased volume. Exclusion Criteria: Less than 15yrs and more than 39yrs and Individuals not fulfilling the inclusion criteria or participating in other clinical trials Information about the variables was gathered by using set of semi structured questionnaires and anthropometric assessment was done by using measuring tape, weighing scale, and standard height rod. Non-invasive sonographic scanning was done to identify polycystic ovaries. Further biochemical examination was done for obtaining the values of prolactin, testosterone, T3, T4,TSH and serum Insulin. Data were analyzed using IBM SPSS statistical software version 22. RESULTS The present study was done for a period of 2 yrs on 100 patients. Out of them 50 from urban and 50 from rural patients of PCOS. The results were as follows. 91

Table 1: Comparison of Details in Rural and Urban RURAL URBAN No. of Patients % No. of Patients % P-value Types of families Nuclear 32 64% 44 88% <0.0001* Joint 18 36% 6 12% Oligomenorrhorhoea 8 16% 32 64% <0.05. * Recent weight Gain 6 12% 26 52% <0.05. * Proportion of Individuals with Obesity Obese 25 50% 44 88% <0.0001* Non obese 25 50% 6 12% Work Activity 20 40% 6 < 0.0001 *Values <0.05 are significant Table 2: Comparison in Rural and Urban areas Rural Urban P-Value No. Of % No. Of % Patients Patients Hirsutism 12 24 % 31 62% <0.05.* Serum testosterone 20 40% 22 44% 0.862 Serum Insulin Raised 20 40% 22 44% 0.783 Within normal 30 60% 28 56% limits Ultra Sono 37 74% 38 76% 0.871 Graphy *Values <0.05 are significant. Figure 2: Bar diagram in Rural and Urban areas Most of the urban participants are from Nuclear Family structure when compared to rural. (88% and 64%). The Propotion of Individuals with oligomenorrhoea were higher among urban participants compared to rural counterparts. Participants had higher proportion of individuals with recent wt. Gain in comparison with rural participants. The proportions of Participants from Urban areas are more Obese than their rural counterparts. 92

The Urban Study Participants had a higher frequency of excess androgen activity which was evidenced by Hirsutism involvement in vigorous work activity was significantly higher among rural. There was no statistically significant difference for serum testosterone level of the rural and urban participants. The proportion of participants diagnosed with polycystic ovarian syndrome serum Insulin levels in rural verses urban (40% verses 44%). The proportion of participants diagnosed with polycystic ovarian Syndrome having polycystic ovaries on ultrasonography finding in rural verses urban (74% verses 76%). DISCUSSION Reproductive phase of life brings multiple physiological, anatomical and psychological changes in the life of women due to familial, cultural and social restrictions most of the women are not able to share and get right advice for menstrual related problems. PCOS is of this condition which is of serious concern. The present study was conducted with the objective to determine the difference in burden of PCOS in rural and urban settings. The results of the study have shown that 20% of participants were diagnosed with PCOS. The proportion of PCOS was higher in urban population in comparison to rural counter parts. Most of the studies so far conducted the prevalence of PCOS in various geographic regions. The reported prevalence of PCOS in various geographical areas ranges between 2.2% and 26%. In Southern China the prevalence was 2.4% among 915 women recruited through offer of a free medical camp. The prevalence of PCOS depends on the recruitment process of the study population, criteria used for its definition, and the screening methods used. Comparison of prevalence of PCOS in different studies: In a study conducted in Sri Lanka on 3.030 women aged 15-39 years, the prevalence was found to be 6.3 %( 95%; L:5.9-6.8%) for the period 2005-2006. A higher prevalence of PCOS (46.8%) was reported among girls aged 13-18 years with euthyroid chronic lymphocyte thyroiditis in a case control study conducted in New Delhi. In a study conducted among girls aged 15-18 years in Andhra Pradesh, the prevalence was noted to be 9.13%.In another study on adolescent in Kerala, prevalence was found to be 26.4%. Rural and urban family structure in Swetha Balaji et al 10 study is 63%, 87% in present study it is 64%, 88% which correlates well.number of urban participants living in nuclear family structure was more when compared to their rural counterpart in both studies. The present study participants presenting with menstrual irregularities like oligomenorrhoea were comparable with other study groups. Proportion of participants presenting with oligomenorrhoea were higher in urban women when compared to their rural counterparts. The present study participants presenting with recent weight gain were comparable with other study groups. Proportion of participants presenting with recent weight gain were higher in urban women when compared to their rural counterparts According to Swetha balaji et al 10 study, complaints of leucorrhoea and weight gain with irregular menses were also reported to be higher in frequency among urban participants. Study of Proportion of individuals with obesity in Rural- Urban areas. In prior study prevalence of obesity as per BMI among rural and urban participants. Study of prevalence of Obesity as per BMI among rural and urban areas. Similar results were reported by Majumdar et al wherein the prevalence rate of obesity was 37.5. 11 A multicentre study involving 7 urban cities in India among age group of 20-40 years indicated that the prevalence of obesity was 30% 12. Lim et al in a systemic review and meta-analysis concluded 40that women with PCOS had a greater risk of overweight, obesity, and central obesity. 13 The present study participants presenting with obesity have been categorised as per BMI, were comparable with other study groups. Proportion of participants presenting with obesity were higher in urban women when compared to their rural counter parts. Swetha Balaji et al 10 study is 40%, 57% in present study it is 50%, 88% which correlates well with our study. Involvement in vigorous work activity was significantly higher among rural participants compared to urban vanes. Obesity aggravates this alone or in combination with other factors. In 2006 Sarkar et al 14 reported that life style changes in the both rural and urban areas have influenced in the prevalence of PCOS. Misra et al 15 reported that lack of exercise and low physical activity play a role in prevalence of PCOS. In the present study the serum testosterone levels were raised in about 21% of total participants. Average testosterone levels of participants were 2.47pg/ml. There was no statistical significance difference for serum testosterone levels of the rural and urban participant s.the present study group results were comparable Swetha Balaji et al study. According to Swetha Balaji et al study, 30% of participants had above normal testosterone levels. 10 93

Demir et al observed in their study that there was no correlation between serum testosterone levels and the rate of hirsutism in PCOS women and the incidence of hirsutism in PCOS women varies widely between different studies (17% to 100%) & hence above mentioned study groups postulated that testosterone sensitivity, 5 alpha reductase activity or environmental/ socioeconomic factors may play role in development of clinical hirsutism. 16 In the present study rural participants diagnosed with PCOS had raised serum insulin levels in 40% when compared to urban participants which were 44%. Insulin resistance and hyperinsulinemia are considered risk factors for development of atherosclerosis and impaired glucose tolerance. Acanthosis nigricans is considered as an important cutaneous marker of hyperinsulinemia. The incidence of acanthosis nigricans in Kala k, Sujata N Datti et al 17 study was 21% and most common site was nape of neck. Study has observed very strong association between acanthosis nigricans and obesity. The prevalence of acanthosis nigricans in adult obese patients has been estimated to be 74% by Hud et al. 18 PCOS is often associated with profound insulin resistance as well as with defects in insulin secretion. These abnormalities, together with obesity, explain the substantially increased prevalence of glucose intolerance in PCOS.PCOS women is inherently insulin resistant with compensatory hyperinsulinemia and this plays a central role in pathogenesis of PCOS. Hyperinsulinemia probably adds at the level of hypothalamic pituitary access and stimulates LH secretion leading to an ovulation with irregular cycle. The fasting insulin levels were significantly higher in the insulin resistance groups (26.26 ± 7.98 vs. 12.72 ± 4.08). In the present study seventy five percent of the study participants had a positive radiology test reflecting presence of poly cystic ovaries.the present study was comparable to other studies- Swetha Balaji et al 10 study and Vijayan CP and Sonia A et al study with similar findings. 19 In the present study the proportion of urban participants diagnosed with PCOS presented with hirsutism were 62% when compared to rural counterparts which were 25%.In Kala k., Sujata N Datti et al 17 study the prevalence of hirsutism was 68%, with no significant difference in obese and non- obese study group. Saxena et al 20 reported prevalence of 89% and 80% in obese and lean PCOS which was statistically insignificant. Demir et al 16 observed in their study that there was no correlation between serum testosterone levels and the rate of hirsutism in PCOS women and the incidence of hirsutism in PCOS women varies widely between different studies(17% to 100%) 16 the present study results were also comparable with Balaji et al 10 study. CONCLUSIONS The crude prevalence rate determined from the present study was 20%. The increased risk of developing Type 2 diabetes in polycystic ovarian syndrome is of immense public health concern especially in India, which has been tagged as a diabetic capital of the world. The reported younger onset of this syndrome and the prevalence of associated risk factors such as glucose intolerance in the Indian population signified a need for intensified efforts in early detection. REFERENCES 1. M. F. Yii, C. E. D. Lim, X. Luo, W. S. F. Wong, N. C. L. Cheng, and X. Zhan, Polycystic ovarian syndrome in adolescence, Gynaecological Endocrinology, 2009;vol. 25, no. 10, pp. 634 639. 2. R. M. Williams, K. K. Ong, and D. B. Dunger, Polycystic ovarian syndrome during puberty and adolescence, Molecular and Cellular Endocrinology, 2013; vol. 373, no. 1-2, pp. 61 67. 3. R. Nidhi, V. Padmalatha, R. Nagarathna, and R. Amritanshu, Prevalence of polycystic ovarian syndrome in Indian adolescents, Journal of Paediatric and Adolescent Gynecology, 2011; vol. 24, no. 4, pp. 223 227. 4. P. Kalra, B. Bansal, P. Nag et al., Abdominal fat distribution and insulin resistance in Indian women with polycystic ovarian syndrome, Fertility and Sterility, 2009; vol. 91, no. 4, pp. 1437 1440. 5. C. N.Wijeyratne, R.D.A.Seneviratne, S.Dahanayake et at., Phenotype and metabolic profile of south asian women with polycystic ovary syndrome(pcos): results of a large database from a specialist Endocrine Clinic, Human Reproduction,2011; vol. 26, no. 1, pp 202-213. 6. B. C. J. M. Fauser, B. C. Tarlatzis, R. W. Rebar, et al., Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group, Fertility and Sterility,2012; vol. 97, no. 1, pp. 28.e25 38.e25. 7. J. Bronstein, S. Tawdekar, Y. Liu, M. Pawelczak, R. David, and B. Shah, Age of onset of polycystic ovarian syndrome in girls may be earlier than previously thought, Journal of Pediatric and Adolescent Gynecology, 2011;vol. 24, no. 1, 15 20. 8. L. Ibáñez, R. Díaz, A. López-Bermejo, and M. V. Marcos, Clinical spectrum of premature pubarche: links to metabolic syndrome and ovarian hyperandrogenism, Reviews in Endocrine and Metabolic Disorders, 2009;vol. 10, no. 1, pp. 63 76. 9. R. B. Singh, M. A. Niaz, S. S. Rastogi, S. Bajaj, Z. Gaoli, and Z. Shoumin, Current zinc intake and risk of diabetes and coronary artery disease and factors 94

associated with insulin resistance in rural and urban populations of north India, Journal of the American College of Nutrition, 1998;vol. 17, no. 6, pp. 564 570. 10. Swetha Balaji,Upadhyay,Chioma Amadi, Awnish K. Singh,Satish Prasad, Jyoti Bala Kasav, Krishna Mohan Surapaneni,Vandana and Ashish Joshi: Urban Rural Comparisons of Polycystic Ovary Syndrome Burden among Adolescent Girls in a Hospital Setting in India BioMed Research International Volume 2015; 158951, 10 11. Majumdar A, Singh TA. Comparison of clinical features and health manifestations in lean vs obese Indian women with polycystic ovarian syndrome. J Hum Reprod Sci 2009; 2:12-17 12. Snehalatha C, Ramachandran A, Kapur A, Vijay V. Age specific prevalence and risk associations for impaired glucose tolerance in urban southern Indian population. J Assoc Physicians India 2003; 51:766-9. 13. S.S. Lim, M.J Davis, R.J Norman and L.J.Moran. Overweight, obesity and central obesity in women with polycystic ovarian syndrome: A systemic review and meta-analysis. Hum Reprod update 2012; 18(6):618-637. 14. Sarkar S, Das M, Mukhopadhyay, Chakarbarti C, Majumdar P: High prevalence of metabolic syndrome & its correlates in two tribal populations of India & the impact of urbanization. Indian J Med Res123 2006; 679-86. 15. Sheehan.M, Polycystic ovarian syndrome: Diagnosis and management. Clinical Medicine & Research, 2004; 2(1), 13-27. 16. Demir B, Pasa S, Demir S, Tumer C, Atay AE, Gul T and Atamer Y. Hirsutism score and the severity of hyperandrogenism associated with polycystic ovarian syndrome in south-eastern region of Turkey. The Journal of International Medical Research 2011; 39:1529-1535. 17. Kala.K, Sujatha. N. Datti, Dayananda: A Study Clinical manifestations of PCOS among obese and non- obese rural women Indian journal of Basic & applied medical Research: 2013: 8:2, 18. Hud Jr JA, Cohen J B, Wagner JM. Prevalance and significance of acanthosis nigricancs in an adult obese population. Arch Dermatol 1992; 128:941-4. 19. Vijayan.CP and Sonia. A Prevalence of Polycystic Ovary Syndrome among students of a teaching collegiate hospital, Department of Obstetrics and Gynaecology, Government Medical-College, Kottayam, Kerala. 20. Saxena P, Prakash A, Nigam A, Mishra A. Polycystic ovarian syndrome: Is obesity a sine qua non? A clinical, hormonal and metabolic assesment in relation to body mass index. Indian J Endocr Metb 2012; 16:996-9. Source of support: Nil Conflict of interest: None declared This work is licensed under CC BY: Creative Commons Attribution 3.0 License. 95